Carlos Blanco
HQ Location: Spain
RANK #430
Carlos Blanco, M.D., Ph.D., M.S. is the Director of the Division of Epidemiology, Services, and Prevention Research at the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health. Dr. Blanco is a national known expert in the epidemiology and treatment of addictive disorders with and without comorbid disorders.
His accomplishments include, among others, a detailed examination of the course and stages of substance use disorders, the development of methods to quantify the generalizability of clinical trials, the development and testing of interventions that combine motivational interviewing with cognitive-behavioral therapy to improve retention and outcome in individuals with addictive disorders, and the creation of a virtual map of psychiatric disorders, based on empirical data, to guide research into the causes of mental disorders
Prior to joining NIDA, Dr. Blanco was Professor of Psychiatry at Columbia University Medical Center and a Research Psychiatrist at the New York State Psychiatric Institute. He is a graduate of Universidad Autónoma de Madrid (Spain) and completed his psychiatry residency at Columbia University, where he also completed a research fellowship. Dr. Blanco has authored over 200 peer-reviewed publications.
Numbers of Unicorns
1
435
Rank (Xs)
#430
Investments
46
Exits
27
Numbers of Unicorns
1
435
Rank (Xs)
#430
Investments
46
Exits
27
All Unicorns
Logo
Company name
ENTRY ROUND
VALUATION at entry ($M)
VALUATION
Glovo
Glovo
Seed
$6M
417
$2500M
All $100M+
Company name
ENTRY ROUND
VALUATION at entry ($M)
VALUATION
2473
Housfy
$6.66M
6
$39.73M
1316
Deporvillage
$20.13M
10
$193M
2415
Holded
Series B
$54.07M
3
$146.05M
The information is provided for informational purposes. The company does not bear any responsibility for the published data.